Induction of cell death by sera from patients with acute brain injury as a mechanism of production of autoantibodies

Arthritis and Rheumatism

Volumn 46, Issue 12, 2002, Pages 3290-3300

  López Escribano, Herminio ^a   Miñambres, Eduardo ^a   Labrador, Moisés ^b   Bartolomé, María José ^a   López Hoyos, Marcos ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; LIPOCORTIN 5; NALOXONE; OPIATE ANTAGONIST; PROPIDIUM IODIDE; PROTEIN BAX;

ADULT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIGEN BINDING; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; BRAIN INJURY; CELL CULTURE; CELL DEATH; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM;

ACUTE DISEASE; ADULT; AGED; AUTOANTIBODIES; BCL-2-ASSOCIATED X PROTEIN; BLOOD PHYSIOLOGY; BRAIN INJURIES; CELL DEATH; CELLS, CULTURED; FEMALE; HUMANS; JURKAT CELLS; MALE; MIDDLE AGED; NALOXONE; NARCOTIC ANTAGONISTS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0036898727     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10684     Document Type: Article

References (37)

1. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-62.
2. Hetts SW. To die or not to die: An overview of apoptosis and its role in disease. JAMA 1998;279:300-7.
3. Rink A, Fung KM, Trojanowski JQ, Lee VM, Neugebauer E, McIntosh TK. Evidence of apoptotic cell death after experimental traumatic brain injury in the rat. Am J Pathol 1995;147:1575-83.
4. Pravdenkova SV, Basnakian AG, James SJ, Andersen BJ. DNA fragmentation and nuclear endonuclease activity in rat brain after severe closed head injury. Brain Res 1996;729:151-5.
5. Clark RS, Kochanek PM, Chen M, Watkins SC, Marion DW, Chen J, et al. Increases in Bcl-2 and cleavage of caspase-1 and caspase-3 in human brain after head injury. FASEB J 1999;13: 813-21.
6. Murakami K, Kawase M, Kondo T, Chan PH. Cellular accumulation of extravasated serum protein and DNA fragmentation following vasogenic edema. J Neurotrauma 1998;15:825-35.
7. Ertel W, Keel M, Stocker R, Imhof HG, Leist M, Steckholzer U, et al. Detectable concentrations of Fas ligand in cerebrospinal fluid after severe head injury. J Neuroimmunol 1997;80:93-6.
8. Lanzavecchia A. How can cryptic epitopes trigger autoimmunity? J Exp Med 1995;181:1945-8.
9. Levine JS, Koh JS. The role of apoptosis in autoimmunity: Immunogen, antigen and accelerant. Semin Nephrol 1999;19: 34-47.
10. Koopman G, Reutelingsperger CP, Kuitjen GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994;84:1415-20.
11. Martin SJ, Finucane DM, Amarante-Mendes GP, O'Brien GA, Green DR. Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J Biol Chem 1996;271:28753-6.
12. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. Lancet 1974;2:81-4.
13. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE: a severity of disease classification system. Crit Care Med 1985;13: 818-28.
14. Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, et al. The APACHE III prognosis system: Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991;100:1619-36.
15. Jennett B, Bond M. Assessment of outcome after severe head brain damage: A practical scale. Lancet 1975;1:480-4.
16. Andrews PJ, Dearden NM, Miller JD. Jugular bulb cannulation: Description of a cannulation technique and validation of a new continuous monitor. Br J Anaesth 1991;67:553-8.
17. Guo R-F, Huber-Lang M, Wang X, Sarma V, Padgaonkar VA, Craig RA, et al. Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis. J Clin Invest 2000;106:1271-80.
18. Fernandez-Fresnedo G, Ramos MA, González-Pardo MC, De Francisco ALM, Lopez-Hoyos M, Arias M. B lymphopenia in uraemia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2. Nephrol Dial Transplant 2000;15:502-10.
19. Benito A, Silva M, Grillot D, Nuñez G, Fernandez-Luna JL. Apoptosis induced by erythroid differentiation of human leukemia cell lines is inhibited by Bcl-xL. Blood 1996;87:3837-43.
20. Pereda I, Bartolome-Pacheco MJ, Martin M, Lopez-Escribano H, Echevarria S, Lopez-Hoyos M. Antitissue transglutaminase antibodies in HIV infection and effect of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2001;27:507-8.
21. Matter L, Schopfer K, Wilhelm JA, Nyffenegger T, Parisot RF, De Robertis EM. Molecular characterization of ribonucleoprotein antigens bound by antinuclear antibodies: A diagnostic evaluation. Arthritis Rheum 1982;25:1278-83.
22. Forman MS, Nakamura M, Mimori T, Gelpi C, Hardin JA. Detection of antibodies to small nuclear ribonucleoproteins and small cytoplasmic ribonucleoproteins using unlabeled cell extracts. Arthritis Rheum 1985;28:1356-61.
23. Nair MPN, Schwartz SA, Polasani R, Hou J, Sweet A, Chadha KC. Immunoregulatory effects of morphine on human lymphocytes. Clin Diagn Lab Immunol 1997;4:127-32.
24. Singhal PC, Kapasi AA, Reddy K, Franki N, Gibbons N, Ding G. Morphine promotes apoptosis in Jurkat cells. J Leukoc Biol 1999;66:650-8.
25. Newcomb JK, Zhao X, Pike BR, Hayes RL. Temporal profile of apoptotic-like changes in neurons and astrocytes following controlled cortical impact injury in the rat. Exp Neurol 1999;158: 76-88.
26. Ying D, Mufson A, Wang R, Shi Y. Fas-mediated cell death promoted by opioids. Nature 1999;397:218.
27. Ientile R, Ginoprelli T, Cannavo G, Picerno I, Piedimonte G. Effect of beta-endorphin on cell growth and cell death in human peripheral blood lymphocytes. J Neuroimmunol 1997;80:87-92.
28. Utz PJ, Anderson P. Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. Arthritis Rheum 1998;41:1152-60.
29. Rosen A, Casciola-Rosen LA. Autoantigens as substrates for apoptotic proteases: Implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ 1999;6:6-12.
30. LeFeber WP, Norris DA, Ryan SR, Huff JC, Lee LA, Kubo M, et al. Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured keratinocytes. J Clin Invest 1984;74: 1545-51.
31. Golan TD, Elkon KB, Gharavi E, Krueger JG. Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation. J Clin Invest 1992;90:1067-76.
32. Mevorach D, Zhou J, Song X, Elkon K. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 1998;188:387-92.
33. Gensler TJ, Hottelet M, Zhang C, Schlossman S, Anderson P, Utz PJ. Monoclonal antibodies derived from BALB/c mice immunized with apoptotic Jurkat T cells recognize known autoantigens. J Autoimmun 2001;16:59-69.
34. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: Endogenous activators of dendritic cells. Nat Med 1999;5:1249-55.
35. Rovere P, Sabbadini MG, Fazzini F, Bondanza A, Zimmermann VS, Rugarli C, et al. Remnants of suicidal cells fostering systemic autoaggression: Apoptosis in the origin and maintenance of autoimmunity. Arthritis Rheum 2000;43:1663-72.
36. Gershov D, Kim S, Brot N, Elkon KB. C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: Implications for systemic autoimmunity. J Exp Med 2000;192:1353-63.
37. Rovere P, Peri G, Fazzini F, Bottazzi B, Doni A, Bondanza A, et al. The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. Blood 2000; 96:4300-6.